• 8

Skin can ‘pre-learn’: Priming cells for regeneration before injury

By: Pohang University of Science and Technology (POSTECH) press team, reporting work by Choi, Kim and colleagues  |  Published in: Nature Communications / EurekAlert! institutional press release  |  April 2026


Diabetic foot wounds are notorious for healing slowly — skin cells move sluggishly, blood vessels don’t regrow well, and inflammation lingers far longer than it should. Most regenerative strategies today only kick in after the wound has already opened. A far more interesting question is whether we can “pre-load” the skin to heal faster before injury ever happens.

A team led by Prof. Sekyu Choi at Pohang University of Science and Technology (POSTECH), with Prof. Jong Kyoung Kim, graduate researchers Minjun Kwak, Eunjun Choi and Yemin Jo, and collaborators at the Institute for Basic Science, The Catholic University of Korea, and the University of Washington, reported exactly that in Nature Communications. Rather than turning entire patches of skin back into embryo-like cells — an approach that carries real tumour risk — they briefly and gently switched on the four classic Yamanaka reprogramming genes (Oct4, Sox2, Klf4, c-Myc) in only a small subset of epidermal cells. Those primed cells quietly pulled their neighbours into a “pre-regenerative” state, activating healing pathways (PI3K-AKT, EGFR, HIF-1α) in advance. When the skin was later wounded, new surface layers formed faster, new blood vessels grew more reliably, immune responses were more tightly regulated, and scars came out smaller — notably, the same benefits appeared in diabetic animals, where healing is usually impaired.

This is an animal study, so patients shouldn’t expect a “pre-healing” prescription any time soon. But it is one of the first credible demonstrations that we can teach skin to anticipate injury, which is especially tantalising for high-risk diabetic feet where a tiny blister can escalate into a limb-threatening ulcer. The honest next steps are big: figuring out how to prime the right patch of skin, at the right dose, in the right human patient, without off-target effects.

📎 Source: Pohang University of Science and Technology press release via EurekAlert! (April 2026) — https://www.eurekalert.org/news-releases/1123389 — reporting Kwak M, Choi E, Jo Y, Kim JK, Choi S, et al., “Mosaic partial epidermal reprogramming remodels neighbors and niches to refine skin homeostasis and repair,” Nature Communications (2026).

Comments

comments

Author

PV Mayer

Dr. Perry Mayer is the Medical Director of The Mayer Institute (TMI), a center of excellence in the treatment of the diabetic foot. He received his undergraduate degree from Queen’s University, Kingston and medical degree from the Royal College of Surgeons in Ireland.